admin, Author at Généthon

Publication: Genethon helps clarify a molecular mechanism of mitochondrial malfunction in Duchenne muscular dystrophy

December 14, 2022

Téléthon 2022: Benjamin, a hope for families thanks to clinical trials

November 21, 2022

Telethon 2022: for Lucie, “a real opportunity, thanks to advances in research”

November 21, 2022

Genethon’s Latest Research, Including Advances in Gene Editing and AAV Delivery Vectors for Gene Therapy, to be Featured at European Society for Gene and Cell Therapy, Oct. 11-14, 2022

October 11, 2022

Publication: Genethon helps identify two vectors optimized for muscles via a European H2020 program

October 5, 2022

First Patient Dosed in Phase 1/2 Clinical Trial in Europe of Gene Therapy for LGMD-R9

September 26, 2022

Genethon to Present Its Latest Gene Therapy Research Advancements in Neuromuscular Diseases at the International Myology 2022 Congress

September 12, 2022

The Genethon platforms obtain ISO 9001 certification

July 20, 2022

Anne Galy receives the WAS Foundation Callahan Award for her work on Wiskott-Aldrich syndrome

July 15, 2022

Sickle-cell anemia: a project involving the Gene editing team has just secured European funding

July 8, 2022